{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T23:20:14Z","timestamp":1781911214512,"version":"3.54.5"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpurol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pediatric Urology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.jpurol.2022.01.021","type":"journal-article","created":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T13:00:31Z","timestamp":1644238831000},"page":"314-319","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Cost comparison of intra-detrusor injection of botulinum toxin versus augmentation cystoplasty for refractory neurogenic detrusor overactivity in children"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8164-0285","authenticated-orcid":false,"given":"Soo Jeong","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quincy G.","family":"Nang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arindam","family":"RoyChoudhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.M.","family":"Kern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunj","family":"Sheth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micah","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dix Phillip","family":"Poppas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ardavan","family":"Akhavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpurol.2022.01.021_bib1","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0022-5347(05)67283-7","article-title":"Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results","volume":"164","author":"Schurch","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.jpurol.2022.01.021_bib2","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.eururo.2003.12.004","article-title":"European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity","volume":"45","author":"Reitz","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.jpurol.2022.01.021_bib3","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0302-2838(03)00136-2","article-title":"Botulinum-a toxin detrusor injection as a novel approach in the treatment of bladder spasticity in children with neurogenic bladder","volume":"44","author":"Schulte-Baukloh","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.jpurol.2022.01.021_bib4","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.urology.2005.05.054","article-title":"Repeated botulinum-A toxin injections in treatment of children with neurogenic detrusor overactivity","volume":"66","author":"Schulte-Baukloh","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.jpurol.2022.01.021_bib5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00383-013-3365-x","article-title":"Repeated injections of intradetrusor onabotulinumtoxinA as adjunctive treatment of children with neurogenic bladder","volume":"30","author":"Sager","year":"2014","journal-title":"Pediatr Surg Int"},{"key":"10.1016\/j.jpurol.2022.01.021_bib6","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.urology.2006.08.1069","article-title":"Persistence of therapeutic effect after repeated injections of botulinum toxin type A to treat incontinence due to neurogenic detrusor overactivity","volume":"68","author":"Karsenty","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.jpurol.2022.01.021_bib7","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.eururo.2008.02.037","article-title":"Histological changes in the urothelium and suburothelium of human overactive bladder following intradetrusor injections of botulinum neurotoxin type A for the treatment of neurogenic or idiopathic detrusor overactivity","volume":"53","author":"Apostolidis","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.jpurol.2022.01.021_bib8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/ene.12524","article-title":"Resource utilization and productivity loss in persons with spina bifida\u2014an observational study of patients in a tertiary urology clinic in Germany","volume":"22","author":"van Nooten","year":"2015","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jpurol.2022.01.021_bib9","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1469-8749.2009.03543.x","article-title":"Expectation of life and unexpected death in open spina bifida: a 40-year complete, non-selective, longitudinal cohort study","volume":"52","author":"Oakeshott","year":"2010","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.jpurol.2022.01.021_bib10","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/S0022-5347(05)00400-3","article-title":"Repeated intradetrusor botulinum toxin type A in children with neurogenic bladder due to myelomeningocele","volume":"175","author":"Altaweel","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.jpurol.2022.01.021_bib11","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jpurol.2014.03.007","article-title":"Cumulative incidence of outcomes and urologic procedures after augmentation cystoplasty","volume":"10","author":"Schlomer","year":"2014","journal-title":"J Pediatr Urol"},{"key":"10.1016\/j.jpurol.2022.01.021_bib12","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1186\/s12913-015-1040-8","article-title":"Predicting inpatient hospital payments in the United States: a retrospective analysis","volume":"15","author":"Smith","year":"2015","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.jpurol.2022.01.021_bib13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00345-010-0618-3","article-title":"Five-year cost analysis of intra-detrusor injection of botulinum toxin type A and augmentation cystoplasty for refractory neurogenic detrusor overactivity","volume":"29","author":"Padmanabhan","year":"2011","journal-title":"World J Urol"},{"key":"10.1016\/j.jpurol.2022.01.021_bib14","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.urology.2018.02.033","article-title":"Intradetrusor injections of botulinum toxin type A in children with spina bifida: a multicenter study","volume":"116","author":"Hascoet","year":"2018","journal-title":"Urology"},{"key":"10.1016\/j.jpurol.2022.01.021_bib15","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.eururo.2011.07.002","article-title":"Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial","volume":"60","author":"Cruz","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.jpurol.2022.01.021_bib16","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/bju.13795","article-title":"Positive outcomes with first onabotulinumtoxinA treatment persist in the long term with repeat treatments in patients with neurogenic detrusor overactivity","volume":"119","author":"Denys","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.jpurol.2022.01.021_bib17","first-page":"763159","article-title":"Pharmacotherapy in pediatric neurogenic bladder intravesical botulinum toxin type a","author":"Sager","year":"2012","journal-title":"ISRN Urol"},{"key":"10.1016\/j.jpurol.2022.01.021_bib18","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.eururo.2010.06.035","article-title":"Efficacy and tolerability of botulinum toxin type A in patients with neurogenic detrusor overactivity and without concomitant anticholinergic therapy: comparison of two doses","volume":"58","author":"Grise","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.jpurol.2022.01.021_bib19","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/PEC.0000000000000202","article-title":"Outpatient management of young febrile infants with urinary tract infections","volume":"30","author":"Schnadower","year":"2014","journal-title":"Pediatr Emerg Care"},{"key":"10.1016\/j.jpurol.2022.01.021_bib20","first-page":"764325","article-title":"Metabolic changes after urinary diversion","author":"Van der Aa","year":"2011","journal-title":"Adv Urol"},{"key":"10.1016\/j.jpurol.2022.01.021_bib21","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1007\/s00345-019-02919-z","article-title":"Augmentation cystoplasty in the patient with neurogenic bladder","volume":"38","author":"Cheng","year":"2020","journal-title":"World J Urol"},{"key":"10.1016\/j.jpurol.2022.01.021_bib22","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s11934-007-0066-9","article-title":"A review of metabolic consequences and long-term complications of enterocystoplasty in children","volume":"8","author":"Hensle","year":"2007","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.jpurol.2022.01.021_bib23","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/iju.13417","article-title":"Lessons learned from the management of adults who have undergone augmentation for spina bifida and bladder exstrophy: incidence and management of the non- lethal complications of bladder augmentation","volume":"25","author":"Husmann","year":"2018","journal-title":"Int J Urol"},{"key":"10.1016\/j.jpurol.2022.01.021_bib24","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/iju.12943","article-title":"Augmentation cystoplasty: urodynamic and metabolic outcomes at 10-year follow-up","volume":"22","author":"Cheng","year":"2015","journal-title":"Int J Urol"},{"key":"10.1016\/j.jpurol.2022.01.021_bib25","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0022-5347(17)40055-3","article-title":"Malignancies in bladder augmentations and intestinal conduits","volume":"143","author":"Filmer","year":"1990","journal-title":"J Urol"},{"key":"10.1016\/j.jpurol.2022.01.021_bib26","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0022-5347(05)00035-2","article-title":"Rectosigmoid pouch (mainz pouch II) in children","volume":"175","author":"Pahernik","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.jpurol.2022.01.021_bib27","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/00365590600991284","article-title":"The rationale behind recommendations for follow-up after urinary diversion: an evidence-based approach","volume":"41","author":"Bakke","year":"2007","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.jpurol.2022.01.021_bib28","doi-asserted-by":"crossref","first-page":"41 e1","DOI":"10.1016\/j.jpurol.2014.08.016","article-title":"Does augmentation cystoplasty with continent reconstruction at a young age increase the risk of complications or secondary surgeries?","volume":"11","author":"Merriman","year":"2015","journal-title":"J Pediatr Urol"},{"key":"10.1016\/j.jpurol.2022.01.021_bib29","doi-asserted-by":"crossref","first-page":"533 e1","DOI":"10.1016\/j.jpurol.2018.05.028","article-title":"Thirty-day hospital readmissions after augmentation cystoplasty: a Nationwide readmissions database analysis","volume":"14","author":"Maldonado","year":"2018","journal-title":"J Pediatr Urol"}],"container-title":["Journal of Pediatric Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477513122000584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477513122000584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:52:17Z","timestamp":1761486737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477513122000584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S1477513122000584"],"URL":"https:\/\/doi.org\/10.1016\/j.jpurol.2022.01.021","relation":{},"ISSN":["1477-5131"],"issn-type":[{"value":"1477-5131","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost comparison of intra-detrusor injection of botulinum toxin versus augmentation cystoplasty for refractory neurogenic detrusor overactivity in children","name":"articletitle","label":"Article Title"},{"value":"Journal of Pediatric Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpurol.2022.01.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Journal of Pediatric Urology Company. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}